Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer ; volume:20 ; number:1 ; day:9 ; month:8 ; year:2018 ; pages:1-5 ; date:12.2018
Arthritis Research & Therapy ; 20, Heft 1 (9.8.2018), 1-5, 12.2018
- Creator
-
Betteridge, Zoe E.
Priest, Lynsey
Cooper, Robert G.
McHugh, Neil J.
Blackhall, Fiona
Lamb, Janine A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-018-1678-9
- URN
-
urn:nbn:de:101:1-2019112718232327728655
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Betteridge, Zoe E.
- Priest, Lynsey
- Cooper, Robert G.
- McHugh, Neil J.
- Blackhall, Fiona
- Lamb, Janine A.
- SpringerLink (Online service)
Other Objects (12)
Bench to bedside review of myositis autoantibodies
Newer Autoantibodies and Laboratory Assessments in Myositis
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
Isolated anti-Ku antibody in scleroderma-myositis overlap syndrome: the histo-pathological patern
Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
Myositis-specific antibodies: Overview and clinical utilization
Bench to bedside review of myositis autoantibodies
Newer Autoantibodies and Laboratory Assessments in Myositis
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
Isolated anti-Ku antibody in scleroderma-myositis overlap syndrome: the histo-pathological patern
Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
Myositis-specific antibodies: Overview and clinical utilization
Bench to bedside review of myositis autoantibodies
Newer Autoantibodies and Laboratory Assessments in Myositis
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
Isolated anti-Ku antibody in scleroderma-myositis overlap syndrome: the histo-pathological patern
Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis